Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
36.35
-0.45 (-1.22%)
At close: Sep 4, 2025, 4:00 PM
36.83
+0.48 (1.32%)
After-hours: Sep 4, 2025, 6:45 PM EDT
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $181.40M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $533.85M. In the year 2024, Caris Life Sciences had annual revenue of $412.26M with 34.67% growth.
Revenue (ttm)
$533.85M
Revenue Growth
+34.67%
P/S Ratio
2.93
Revenue / Employee
$301,779
Employees
1,769
Market Cap
10.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 3 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 3 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 3 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 3 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC